Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 790

1.

Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis.

Yamada T, Miyabe Y, Ueki S, Fujieda S, Tokunaga T, Sakashita M, Kato Y, Ninomiya T, Kawasaki Y, Suzuki S, Saito H.

Front Immunol. 2019 Feb 4;10:74. doi: 10.3389/fimmu.2019.00074. eCollection 2019.

2.

Prediction of risk of falls based on handgrip strength in chronic liver disease patients living independently.

Hiraoka A, Tamura R, Oka M, Izumoto H, Ueki H, Tsuruta M, Yoshino T, Ono A, Aibiki T, Okudaira T, Yamago H, Suga Y, Iwasaki R, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Hirooka M, Abe M, Matsuura B, Hiasa Y, Kino T, Yamamoto K, Michitaka K.

Hepatol Res. 2019 Feb 16. doi: 10.1111/hepr.13322. [Epub ahead of print]

PMID:
30770617
3.

Dietary inflammatory index positively associated with high-sensitivity C-reactive protein level in Japanese from NIPPON DATA2010.

Yang Y, Hozawa A, Kogure M, Narita A, Hirata T, Nakamura T, Tsuchiya N, Nakaya N, Ninomiya T, Okuda N, Kadota A, Ohkubo T, Okamura T, Ueshima H, Okayama A, Miura K.

J Epidemiol. 2019 Feb 9. doi: 10.2188/jea.JE20180156. [Epub ahead of print]

4.

A Novel Combination Cancer Therapy with Iron Chelator Targeting Cancer Stem Cells via Suppressing Stemness.

Katsura Y, Ohara T, Noma K, Ninomiya T, Kashima H, Kato T, Sato H, Komoto S, Narusaka T, Tomono Y, Xing B, Chen Y, Tazawa H, Kagawa S, Shirakawa Y, Kasai T, Seno M, Matsukawa A, Fujiwara T.

Cancers (Basel). 2019 Feb 3;11(2). pii: E177. doi: 10.3390/cancers11020177.

5.

Apparent Treatment-Resistant Hypertension and Cardiovascular Risk in Hemodialysis Patients: Ten-Year Outcomes of the Q-Cohort Study.

Tanaka S, Ninomiya T, Hiyamuta H, Taniguchi M, Tokumoto M, Masutani K, Ooboshi H, Nakano T, Tsuruya K, Kitazono T.

Sci Rep. 2019 Jan 31;9(1):1043. doi: 10.1038/s41598-018-37961-1.

6.

Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and meta-analysis.

Toyama T, Neuen BL, Jun M, Ohkuma T, Neal B, Jardine M, Heerspink HL, Wong MG, Ninomiya T, Wada T, Perkovic V.

Diabetes Obes Metab. 2019 Jan 29. doi: 10.1111/dom.13648. [Epub ahead of print]

PMID:
30697905
7.

Cardiovascular Risk Factors Associated With Venous Thromboembolism.

Gregson J, Kaptoge S, Bolton T, Pennells L, Willeit P, Burgess S, Bell S, Sweeting M, Rimm EB, Kabrhel C, Zöller B, Assmann G, Gudnason V, Folsom AR, Arndt V, Fletcher A, Norman PE, Nordestgaard BG, Kitamura A, Mahmoodi BK, Whincup PH, Knuiman M, Salomaa V, Meisinger C, Koenig W, Kavousi M, Völzke H, Cooper JA, Ninomiya T, Casiglia E, Rodriguez B, Ben-Shlomo Y, Després JP, Simons L, Barrett-Connor E, Björkelund C, Notdurfter M, Kromhout D, Price J, Sutherland SE, Sundström J, Kauhanen J, Gallacher J, Beulens JWJ, Dankner R, Cooper C, Giampaoli S, Deen JF, Gómez de la Cámara A, Kuller LH, Rosengren A, Svensson PJ, Nagel D, Crespo CJ, Brenner H, Albertorio-Diaz JR, Atkins R, Brunner EJ, Shipley M, Njølstad I, Lawlor DA, van der Schouw YT, Selmer RM, Trevisan M, Verschuren WMM, Greenland P, Wassertheil-Smoller S, Lowe GDO, Wood AM, Butterworth AS, Thompson SG, Danesh J, Di Angelantonio E, Meade T; Emerging Risk Factors Collaboration.

JAMA Cardiol. 2019 Feb 1;4(2):163-173. doi: 10.1001/jamacardio.2018.4537.

PMID:
30649175
8.

Steno-Stiffness Approach for Cardiovascular Disease Risk Assessment in Primary Prevention.

Tomiyama H, Ohkuma T, Ninomiya T, Mastumoto C, Kario K, Hoshide S, Kita Y, Inoguchi T, Maeda Y, Kohara K, Tabara Y, Nakamura M, Ohkubo T, Watada H, Munakata M, Ohishi M, Ito N, Nakamura M, Shoji T, Vlachopoulos C, Aboyans V, Yamashina A; Collaborative Group for J-BAVELs (Japan Brachial-Ankle Pulse Wave Velocity Individual Participant Data Meta-Analysis of Prospective Studies).

Hypertension. 2019 Mar;73(3):508-513. doi: 10.1161/HYPERTENSIONAHA.118.12110. No abstract available.

PMID:
30636553
9.

Longitudinal Changes of Physical Activity and Sedentary Time in the Middle-Aged and Older Japanese Population: The Hisayama Study.

Yonemoto K, Honda T, Kishimoto H, Yoshida D, Hata J, Mukai N, Shibata M, Hirakawa Y, Ninomiya T, Kumagai S.

J Phys Act Health. 2019 Feb 1;16(2):165-171. doi: 10.1123/jpah.2017-0701. Epub 2019 Jan 11.

PMID:
30634879
10.

Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis.

Okazaki S, Morimoto T, Kamatani Y, Kamimura T, Kobayashi H, Harada K, Tomita T, Higashiyama A, Takahashi JC, Nakagawara J, Koga M, Toyoda K, Washida K, Saito S, Takahashi A, Hirata M, Matsuda K, Mochizuki H, Chong M, Paré G, O'Donnell M, Ago T, Hata J, Ninomiya T, Dichgans M, Debette S, Kubo M, Koizumi A, Ihara M.

Circulation. 2019 Jan 8;139(2):295-298. doi: 10.1161/CIRCULATIONAHA.118.038439. No abstract available.

PMID:
30615506
11.

Having few remaining teeth is associated with a low nutrient intake and low serum albumin levels in middle-aged and older Japanese individuals: findings from the NIPPON DATA2010.

Nakamura M, Ojima T, Nagahata T, Kondo I, Ninomiya T, Yoshita K, Arai Y, Ohkubo T, Murakami K, Nishi N, Murakami Y, Takashima N, Okuda N, Kadota A, Miyagawa N, Kondo K, Okamura T, Ueshima H, Okayama A, Miura K; NIPPON DATA2010 Research Group.

Environ Health Prev Med. 2019 Jan 5;24(1):1. doi: 10.1186/s12199-018-0752-x.

12.

Dietary Sodium Reduction Reduces Albuminuria: A Cluster Randomized Trial.

Jardine MJ, Li N, Ninomiya T, Feng X, Zhang J, Shi J, Zhang Y, Zhang R, Zhang J, Hao J, Perkovic V, Heerspink HL, Wu Y, Yan LL, Neal B.

J Ren Nutr. 2018 Dec 24. pii: S1051-2276(18)30247-4. doi: 10.1053/j.jrn.2018.10.009. [Epub ahead of print]

PMID:
30591358
13.

Author response: Prevalence of and risk factors for cerebral microbleeds in a general Japanese elderly community.

Hata J, Yubi T, Ninomiya T.

Neurol Clin Pract. 2018 Dec;8(6):464-465. doi: 10.1212/CPJ.0000000000000563. No abstract available.

PMID:
30588373
14.

Rapid and Long-term Response of Pulmonary Pleomorphic Carcinoma to Nivolumab: A Case Report.

Senoo S, Ninomiya T, Makimoto G, Nishii K, Kano H, Watanabe H, Hata Y, Kubo T, Tanaka T, Hotta K, Maeda Y, Kiura K.

Intern Med. 2018 Dec 18. doi: 10.2169/internalmedicine.0890-18. [Epub ahead of print]

15.

[ALLERGIC RHINITIS・CHRONIC RHINOSINUSITIS].

Fujieda S, Kato Y, Ninomiya T.

Arerugi. 2018;67(10):1379-1386. doi: 10.15036/arerugi.67.1379. Japanese. No abstract available.

PMID:
30541972
16.

Decline in handgrip strength from midlife to late-life is associated with dementia in a Japanese community: the Hisayama Study.

Hatabe Y, Shibata M, Ohara T, Oishi E, Yoshida D, Honda T, Hata J, Kanba S, Kitazono T, Ninomiya T.

J Epidemiol. 2018 Dec 8. doi: 10.2188/jea.JE20180137. [Epub ahead of print]

17.

Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol.

Ninomiya T, Ishikawa N, Inoue K, Kubo T, Yasugi M, Shibayama T, Maeda T, Fujitaka K, Kodani M, Yokoyama T, Kuyama S, Ochi N, Ueda Y, Miyoshi S, Kozuki T, Amano Y, Kubota T, Sugimoto K, Bessho A, Ishii T, Watanabe K, Oze I, Hotta K, Kiura K.

Clin Lung Cancer. 2018 Nov 1. pii: S1525-7304(18)30292-4. doi: 10.1016/j.cllc.2018.10.008. [Epub ahead of print]

PMID:
30514667
18.

Serum Soluble Triggering Receptor Expressed on Myeloid Cells 2 as a Biomarker for Incident Dementia: The Hisayama Study.

Ohara T, Hata J, Tanaka M, Honda T, Yamakage H, Yoshida D, Inoue T, Hirakawa Y, Kusakabe T, Shibata M, Teraoka T, Kitazono T, Kanba S, Satoh-Asahara N, Ninomiya T.

Ann Neurol. 2019 Jan;85(1):47-58. doi: 10.1002/ana.25385. Epub 2018 Dec 28.

PMID:
30485483
19.

Development and validation of modified risk prediction models for cardiovascular disease and its subtypes: The Hisayama Study.

Honda T, Yoshida D, Hata J, Hirakawa Y, Ishida Y, Shibata M, Sakata S, Kitazono T, Ninomiya T.

Atherosclerosis. 2018 Dec;279:38-44. doi: 10.1016/j.atherosclerosis.2018.10.014. Epub 2018 Oct 17.

PMID:
30408715
20.

Objectively measured sedentary time and diabetes mellitus in a general Japanese population: The Hisayama Study.

Honda T, Kishimoto H, Mukai N, Hata J, Yoshida D, Hirakawa Y, Shibata M, Ohara T, Kumagai S, Ninomiya T.

J Diabetes Investig. 2018 Nov 2. doi: 10.1111/jdi.12968. [Epub ahead of print]

21.

Distribution of nephrologists and regional variation in the clinical severity of IgA nephropathy at biopsy diagnosis in Japan: a cross-sectional study.

Okabayashi Y, Tsuboi N, Amano H, Miyazaki Y, Kawamura T, Ogura M, Narita I, Ninomiya T, Yokoyama H, Yokoo T.

BMJ Open. 2018 Oct 31;8(10):e024317. doi: 10.1136/bmjopen-2018-024317.

22.

Risk prediction of severe reaction to oral challenge test of cow's milk.

Kawahara T, Tezuka J, Ninomiya T, Honjo S, Masumoto N, Nanishi M, Nakayama H, Ohga S.

Eur J Pediatr. 2019 Feb;178(2):181-188. doi: 10.1007/s00431-018-3274-z. Epub 2018 Oct 30.

PMID:
30377799
23.

Cancer-associated fibroblasts (CAFs) promote the lymph node metastasis of esophageal squamous cell carcinoma.

Kashima H, Noma K, Ohara T, Kato T, Katsura Y, Komoto S, Sato H, Katsube R, Ninomiya T, Tazawa H, Shirakawa Y, Fujiwara T.

Int J Cancer. 2019 Feb 15;144(4):828-840. doi: 10.1002/ijc.31953. Epub 2018 Dec 3.

PMID:
30367467
24.

A potential novel pathological implication of serum soluble triggering receptor expressed on myeloid cell 2 in insulin resistance in a general Japanese population: The Hisayama study.

Tanaka M, Honda T, Yamakage H, Hata J, Yoshida D, Hirakawa Y, Shibata M, Inoue T, Kusakabe T, Satoh-Asahara N, Ninomiya T.

Diabetes Res Clin Pract. 2018 Dec;146:225-232. doi: 10.1016/j.diabres.2018.10.007. Epub 2018 Oct 16.

PMID:
30339787
25.

Japanese Legacy Cohort Studies: The Hisayama Study.

Ninomiya T.

J Epidemiol. 2018 Nov 5;28(11):444-451. doi: 10.2188/jea.JE20180150. Epub 2018 Oct 6.

26.

Forced expression of mouse progerin attenuates the osteoblast differentiation interrupting β-catenin signal pathway in vitro.

Tsukune N, Naito M, Ohashi A, Ninomiya T, Sato S, Takahashi T.

Cell Tissue Res. 2018 Oct 3. doi: 10.1007/s00441-018-2930-y. [Epub ahead of print]

PMID:
30284086
27.

Reply to "Long sleep duration: An epiphenomenon or a risk for dementia?"

Ohara T, Ninomiya T.

J Am Geriatr Soc. 2018 Nov;66(11):2225-2226. doi: 10.1111/jgs.15558. Epub 2018 Sep 28. No abstract available.

PMID:
30264859
28.

[The Elucidation of Tumor Immunosuppression Affected by Cancer-Associated Fibroblasts].

Kato T, Noma K, Katsura Y, Sato H, Kohmoto S, Ninomiya T, Ohara T, Tazawa H, Kagawa S, Shirakawa Y, Fujiwara T.

Gan To Kagaku Ryoho. 2018 Sep;45(9):1279-1281. Japanese.

PMID:
30237368
29.

Social reward monitoring and valuation in the macaque brain.

Noritake A, Ninomiya T, Isoda M.

Nat Neurosci. 2018 Oct;21(10):1452-1462. doi: 10.1038/s41593-018-0229-7. Epub 2018 Sep 17.

PMID:
30224807
30.

Periodontal status and lung function decline in the community: the Hisayama study.

Takeuchi K, Matsumoto K, Furuta M, Fukuyama S, Takeshita T, Ogata H, Suma S, Shibata Y, Shimazaki Y, Hata J, Ninomiya T, Nakanishi Y, Inoue H, Yamashita Y.

Sci Rep. 2018 Sep 6;8(1):13354. doi: 10.1038/s41598-018-31610-3.

31.

Study Protocol: Phase-Ib Trial of Nivolumab Combined With Metformin for Refractory/Recurrent Solid Tumors.

Kubo T, Ninomiya T, Hotta K, Kozuki T, Toyooka S, Okada H, Fujiwara T, Udono H, Kiura K.

Clin Lung Cancer. 2018 Nov;19(6):e861-e864. doi: 10.1016/j.cllc.2018.07.010. Epub 2018 Aug 9.

PMID:
30172698
32.

Cathepsin K inhibitor causes changes in crystallinity and crystal structure of newly-formed mandibular bone in rats.

Yoshioka Y, Yamachika E, Nakanishi M, Ninomiya T, Nakatsuji K, Kobayashi Y, Fujii T, Iida S.

Br J Oral Maxillofac Surg. 2018 Oct;56(8):732-738. doi: 10.1016/j.bjoms.2018.08.003. Epub 2018 Aug 18.

PMID:
30131193
33.

Tongue Microbiota and Oral Health Status in Community-Dwelling Elderly Adults.

Asakawa M, Takeshita T, Furuta M, Kageyama S, Takeuchi K, Hata J, Ninomiya T, Yamashita Y.

mSphere. 2018 Aug 15;3(4). pii: e00332-18. doi: 10.1128/mSphere.00332-18.

34.

Prevalence of and risk factors for cerebral microbleeds in a general Japanese elderly community.

Yubi T, Hata J, Ohara T, Mukai N, Hirakawa Y, Yoshida D, Gotoh S, Hirabayashi N, Furuta Y, Ago T, Kitazono T, Kiyohara Y, Ninomiya T.

Neurol Clin Pract. 2018 Jun;8(3):223-231. doi: 10.1212/CPJ.0000000000000464.

PMID:
30105162
35.

Combination therapy with montelukast and loratadine alleviates pharyngolaryngeal symptoms related to seasonal allergic rhinitis.

Imoto Y, Takabayashi T, Sakashita M, Tokunaga T, Morikawa T, Ninomiya T, Okamoto M, Narita N, Fujieda S.

J Allergy Clin Immunol Pract. 2018 Aug 10. pii: S2213-2198(18)30506-3. doi: 10.1016/j.jaip.2018.07.034. [Epub ahead of print] No abstract available.

PMID:
30103031
36.

Prevalence and Risk Factors for Polypoidal Choroidal Vasculopathy in a General Japanese Population: The Hisayama Study.

Fujiwara K, Yasuda M, Hata J, Oshima Y, Hashimoto S, Yoshitomi T, Kiyohara Y, Ishibashi T, Ninomiya T, Sonoda KH.

Semin Ophthalmol. 2018;33(6):813-819. doi: 10.1080/08820538.2018.1506483. Epub 2018 Aug 7.

PMID:
30084710
37.

Development of social systems neuroscience using macaques.

Isoda M, Noritake A, Ninomiya T.

Proc Jpn Acad Ser B Phys Biol Sci. 2018;94(7):305-323. doi: 10.2183/pjab.94.020. Review.

38.

Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes.

Oshima M, Toyama T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K, Araki S, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Shimizu M, Hara A, Makino H, Wada T; Research Group of Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan.

PLoS One. 2018 Aug 2;13(8):e0201535. doi: 10.1371/journal.pone.0201535. eCollection 2018.

39.

Periostin as a novel biomarker for postoperative recurrence of chronic rhinosinitis with nasal polyps.

Ninomiya T, Noguchi E, Haruna T, Hasegawa M, Yoshida T, Yamashita Y, Okano M, Yoshida N, Haruna S, Sakuma Y, Ohta S, Ono J, Izuhara K, Okada M, Kidoguchi M, Tokunaga T, Okamoto M, Kanno M, Sakashita M, Takabayashi T, Narita N, Fujieda S.

Sci Rep. 2018 Jul 30;8(1):11450. doi: 10.1038/s41598-018-29612-2.

40.

Combined effect of cabozantinib and gefitinib in crizotinib-resistant lung tumors harboring ROS1 fusions.

Kato Y, Ninomiya K, Ohashi K, Tomida S, Makimoto G, Watanabe H, Kudo K, Matsumoto S, Umemura S, Goto K, Ichihara E, Ninomiya T, Kubo T, Sato A, Hotta K, Tabata M, Toyooka S, Maeda Y, Kiura K.

Cancer Sci. 2018 Oct;109(10):3149-3158. doi: 10.1111/cas.13752. Epub 2018 Sep 11.

41.

Physical component Quality of life (QOL) reflects the impact of time and moderate chronic kidney disease, unlike SF-6D utility and mental component SF-36 QOL: an AUSDiab analysis.

Wong MG, Ninomiya T, Liyanage T, Sukkar L, Hirakawa Y, Wang Y, Wyld ML, Morton RL, Chadban S, Howard K, Jardine MJ.

Nephrology (Carlton). 2018 Jul 24. doi: 10.1111/nep.13445. [Epub ahead of print]

PMID:
30039893
42.

Social cognition and metacognition contribute to accuracy for self-evaluation of real-world functioning in patients with schizophrenia.

Nishida K, Toyomaki A, Koshikawa Y, Niimura H, Morimoto T, Tani M, Inada K, Ninomiya T, Hori H, Manabe J, Katsuki A, Kubo T, Shirahama M, Kohno K, Kinoshita T, Kusumi I, Iwanami A, Ueno T, Kishimoto T, Terao T, Nakagome K, Sumiyoshi T.

Schizophr Res. 2018 Dec;202:426-428. doi: 10.1016/j.schres.2018.06.071. Epub 2018 Jul 14. No abstract available.

43.

Integrated analysis of human genetic association study and mouse transcriptome suggests LBH and SHF genes as novel susceptible genes for amyloid-β accumulation in Alzheimer's disease.

Yamaguchi-Kabata Y, Morihara T, Ohara T, Ninomiya T, Takahashi A, Akatsu H, Hashizume Y, Hayashi N, Shigemizu D, Boroevich KA, Ikeda M, Kubo M, Takeda M, Tsunoda T.

Hum Genet. 2018 Jul;137(6-7):521-533. doi: 10.1007/s00439-018-1906-z. Epub 2018 Jul 13.

44.

Serum 1,25-Dihydroxyvitamin D Level Is Inappropriate for Use in Prospective Studies of Cancer Incidence - Reply.

Umehara K, Mukai N, Kitazono T, Hoka S, Kiyohara Y, Ninomiya T.

Circ J. 2018 Jul 25;82(8):2216. doi: 10.1253/circj.CJ-17-0909. Epub 2018 Jul 11. No abstract available.

45.

Proposed a simple score for recommendation of scheduled ultrasonography surveillance for hepatocellular carcinoma after Direct Acting Antivirals: multicenter analysis.

Hiraoka A, Kumada T, Ogawa C, Kariyama K, Morita M, Nouso K, Toyoda H, Tada T, Ochi M, Murakami T, Izumoto H, Ueki H, Kitahata S, Aibiki T, Okudaira T, Yamago H, Iwasaki R, Tomida H, Miyamoto Y, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Michitaka K.

J Gastroenterol Hepatol. 2019 Feb;34(2):436-441. doi: 10.1111/jgh.14378. Epub 2018 Jul 29.

PMID:
29996177
46.

DNA Methylation of Proximal PLAT Promoter in Chronic Rhinosinusitis With Nasal Polyps.

Kidoguchi M, Noguchi E, Nakamura T, Ninomiya T, Morii W, Yoshida K, Morikawa T, Kato Y, Imoto Y, Sakashita M, Takabayashi T, Fujieda S.

Am J Rhinol Allergy. 2018 Sep;32(5):374-379. doi: 10.1177/1945892418782236. Epub 2018 Jul 2.

PMID:
29962211
47.

Clinical characteristics and management of gastric tube cancer after esophagectomy.

Shirakawa Y, Noma K, Maeda N, Ninomiya T, Tanabe S, Kikuchi S, Kuroda S, Nishizaki M, Kagawa S, Kawahara Y, Okada H, Fujiwara T.

Esophagus. 2018 Jul;15(3):180-189. doi: 10.1007/s10388-018-0611-2. Epub 2018 Mar 27.

PMID:
29951985
48.

Acetabular revision using a Kerboull-type reinforcement device through direct anterior approach.

Tamaki T, Ninomiya T, Jonishi K, Miura Y, Oinuma K, Shiratsuchi H.

J Orthop Surg (Hong Kong). 2018 May-Aug;26(2):2309499018782553. doi: 10.1177/2309499018782553.

PMID:
29945476
49.

Randomized Phase II Study Comparing Mannitol with Furosemide for the Prevention of Renal Toxicity Induced by Cisplatin-based Chemotherapy with Short-term Low-volume Hydration in Advanced Non-small Cell Lung Cancer: The OLCSG1406 Study Protocol.

Makimoto G, Ichihara E, Hotta K, Ninomiya K, Oze I, Minami D, Ninomiya T, Kubo T, Ohashi K, Tabata M, Maeda Y, Kiura K.

Acta Med Okayama. 2018 Jun;72(3):319-323. doi: 10.18926/AMO/56080.

50.

Cancer-Associated Fibroblasts Affect Intratumoral CD8+ and FoxP3+ T Cells Via IL6 in the Tumor Microenvironment.

Kato T, Noma K, Ohara T, Kashima H, Katsura Y, Sato H, Komoto S, Katsube R, Ninomiya T, Tazawa H, Shirakawa Y, Fujiwara T.

Clin Cancer Res. 2018 Oct 1;24(19):4820-4833. doi: 10.1158/1078-0432.CCR-18-0205. Epub 2018 Jun 19.

PMID:
29921731

Supplemental Content

Loading ...
Support Center